Matsui Hotaka, Sopko Nikolai A, Hannan Johanna L, Bivalacqua Trinity J
The James Buchanan Brady Urological Institute, 600 N. Wolfe Street / Marburg 420, Baltimore, Maryland, 21287, USA.
Curr Drug Targets. 2015;16(5):411-9. doi: 10.2174/138945011605150504114041.
Erectile dysfunction (ED) is a major health problem as the population ages. Basic science research for the last two decades has expanded the knowledge on ED and identified several key molecular changes associated with the pathogenesis of ED, including nitric oxide (NO) / cyclic guanosine monophosphate (cGMP) / protein kinase G (PKG) pathway, RhoA/Rho-associated protein kinase (ROCK) signaling pathway, reactive oxygen species (ROS), renin-angiotensin system (RAS) and tumor necrosis factor-alpha (TNF-α). The causes of ED are classified into aging, vasculogenic, neurogenic, endocrinological, drug-induced and psychogenic. ED is often associated with systemic diseases, such as diabetes and cardiovascular diseases. In this review, we will review the molecular mechanisms of ED and known mechanisms behind ED associated with systemic diseases.
随着人口老龄化,勃起功能障碍(ED)成为一个主要的健康问题。过去二十年的基础科学研究扩展了对ED的认识,并确定了与ED发病机制相关的几个关键分子变化,包括一氧化氮(NO)/环磷酸鸟苷(cGMP)/蛋白激酶G(PKG)途径、RhoA/Rho相关蛋白激酶(ROCK)信号通路、活性氧(ROS)、肾素-血管紧张素系统(RAS)和肿瘤坏死因子-α(TNF-α)。ED的病因分为衰老、血管性、神经性、内分泌性、药物性和心理性。ED常与全身性疾病相关,如糖尿病和心血管疾病。在本综述中,我们将回顾ED的分子机制以及与全身性疾病相关的ED背后的已知机制。